Apatinib plus icotinib in treating advanced non-small-cell lung cancer after icotinib treatment failure.

Xu, JP; Liu, XY; Yang, S; Zhang, XR; Shi, YK

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):